LDS buys Kaolectrolyte, Prodium
This article was originally published in The Tan Sheet
Executive Summary
Cedar Rapids, Iowa-based LDS Consumer Products acquires U.S. marketing, distribution rights to Kaolectrolyte oral rehydration therapy for infants, children under six and Prodium urinary tract infection treatment from Requa, firm announces June 6. Kaolectrolyte competes against Ross' Pedialyte, while Prodium competitors include J&J's Uristat and PolyMedica's Azo-Standard; all three contain active phenazopyridine 95 mg. LDS obtained exclusive U.S. sales and marketing rights to Wartner Wart Removal System in 2002 (1"The Tan Sheet" April 28, 2003, p. 4)...
You may also be interested in...
Wartner Cryotherapy Product Looks To Freeze Wart Removal Competition
LDS Consumer Products' Wartner is the first OTC wart removal product featuring cryotherapy technology, according to the Cedar Rapids, Iowa-based firm
Aldeyra Hopes To Refile Dry Eye Drug Reproxalap Later In 2024
Following an FDA complete response letter last November, Aldeyra has agreed with the agency on a trial design to demonstrate efficacy in ocular discomfort, which the company can complete this year.
Colorado Price Cap Plan For Enbrel Draws Amgen Lawsuit; Cosentyx, Stelara ‘Affordability’ Reviews Pending
However, the state's recently formed prescription drug affordability board found Gilead’s Genvoya and Vertex’s Trikafta to be affordable.